Hurrying up but not rushing, acting and not reacting, good sense and not common sense: Open thoughts and reasonable doubts on COVID-19 vaccination strategies in cancer patients.
作者信息
Loupakis Fotios, Giusti Raffaele, Di Maio Massimo
机构信息
Unit of Oncology 1, Department of Oncology, Istituto Oncologico Veneto IRCCS, Padua, Italy.
Unit of Oncology 1, Medical Oncology Unit, Sant'Andrea Hospital of Rome, Rome, Italy.
出版信息
Crit Rev Oncol Hematol. 2021 Nov;167:103271. doi: 10.1016/j.critrevonc.2021.103271. Epub 2021 Feb 26.
Abstract
摘要
相似文献
1
Hurrying up but not rushing, acting and not reacting, good sense and not common sense: Open thoughts and reasonable doubts on COVID-19 vaccination strategies in cancer patients.
Crit Rev Oncol Hematol. 2021 Nov;167:103271. doi: 10.1016/j.critrevonc.2021.103271. Epub 2021 Feb 26.
2
[COVID-19 vaccination of cancer patients].
Tidsskr Nor Laegeforen. 2021 Jan 15;141(3). doi: 10.4045/tidsskr.21.0026. Print 2021 Feb 23.
3
An Open Letter: COVID-19 and Cancer.
Cancer. 2021 Apr 15;127(8):1171. doi: 10.1002/cncr.33576.
4
COVID-19 vaccination for cancer patients: Evidence, priority, and practice.
Vaccine. 2021 Aug 23;39(36):5075-5077. doi: 10.1016/j.vaccine.2021.07.063. Epub 2021 Jul 24.
5
COVID-19 vaccination in pediatric cancer patients: A high priority.
Pediatr Blood Cancer. 2021 Dec;68(12):e29397. doi: 10.1002/pbc.29397. Epub 2021 Oct 11.
6
COVID-19 vaccination for children with cancer.
Pediatr Blood Cancer. 2022 Feb;69(2):e29340. doi: 10.1002/pbc.29340. Epub 2021 Sep 14.
7
Medical Oncology Group of Australia position statement: COVID-19 vaccination in patients with solid tumours.
Intern Med J. 2021 Jun;51(6):955-959. doi: 10.1111/imj.15339.
8
COVID-19 vaccination: the VOICE for patients with cancer.
Nat Med. 2021 Apr;27(4):568-569. doi: 10.1038/s41591-021-01240-w.
9
Effectiveness of SARS-CoV-2 vaccination in liver transplanted patients: The debate is open!
J Hepatol. 2022 Jan;76(1):237-239. doi: 10.1016/j.jhep.2021.07.034. Epub 2021 Aug 3.
10
Brief Research Report: Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 Vaccination.
Front Immunol. 2022 Jul 5;13:908108. doi: 10.3389/fimmu.2022.908108. eCollection 2022.
引用本文的文献
1
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study.
Cancers (Basel). 2021 Mar 16;13(6):1324. doi: 10.3390/cancers13061324.
本文引用的文献
1
The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Front Immunol. 2020 Jul 21;11:1817. doi: 10.3389/fimmu.2020.01817. eCollection 2020.
2
Caring for Patients With Cancer During the COVID-19 Outbreak in Italy.
JAMA Oncol. 2020 Jun 1;6(6):821-822. doi: 10.1001/jamaoncol.2020.1426.
3
Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists' perspective.
ESMO Open. 2020 Mar;5(2). doi: 10.1136/esmoopen-2020-000759.
4
First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020.
Euro Surveill. 2020 Mar;25(9). doi: 10.2807/1560-7917.ES.2020.25.9.2000178.
5
Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
J Clin Oncol. 2020 Apr 1;38(10):1081. doi: 10.1200/JCO.19.03141. Epub 2020 Feb 4.
6
Predicting Life Expectancy for Older Adults with Cancer in Clinical Practice: Implications for Shared Decision-making.
Curr Oncol Rep. 2019 Jun 25;21(8):68. doi: 10.1007/s11912-019-0821-3.
7
Critical evaluation of oncology clinical practice guidelines.
J Clin Oncol. 2013 Jul 10;31(20):2563-8. doi: 10.1200/JCO.2012.46.8371. Epub 2013 Jun 10.
Zotero 插件